Intellia Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. SKA-B
5. PBA
6. CCH:LN
7. META
8. CCHGY
9. PRY:IM
10. PRYMY

Go back to Intellia Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress

Intellia Therapeutics (NTLA) Tops Q3 EPS by 12c

November 9, 2023 7:31 AM EST

Intellia Therapeutics (NASDAQ: NTLA) reported Q3 EPS of ($1.38), $0.12 better than the analyst estimate of ($1.50). Revenue for the quarter came in at $12 million versus the consensus estimate of $12.45 million.

For earnings history and earnings-related data on Intellia Therapeutics (NTLA) click here.

... More